Literature DB >> 29516544

U2AF1 mutation variants in myelodysplastic syndromes and their clinical correlates.

Ayalew Tefferi1, Mythri Mudireddy1, Christy M Finke1, Maura Nicolosi1, Terra L Lasho1, Curtis A Hanson2, Mrinal M Patnaik1, Animesh Pardanani1, Naseema Gangat1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29516544     DOI： 10.1002/ajh.25084

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  5 in total

Review 1.  Roles and mechanisms of alternative splicing in cancer - implications for care.

Authors:  Sophie C Bonnal; Irene López-Oreja; Juan Valcárcel
Journal:  Nat Rev Clin Oncol       Date:  2020-04-17       Impact factor: 66.675

2.  SRSF2 Mutations in Uveal Melanoma: A Preference for In-Frame Deletions?

Authors:  Natasha M van Poppelen; Wojtek Drabarek; Kyra N Smit; Jolanda Vaarwater; Tom Brands; Dion Paridaens; Emine Kiliç; Annelies de Klein
Journal:  Cancers (Basel)       Date:  2019-08-17       Impact factor: 6.639

3.  Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia.

Authors:  Arnold Kloos; Konstantinos Mintzas; Lina Winckler; Razif Gabdoulline; Yasmine Alwie; Nidhi Jyotsana; Nadine Kattre; Renate Schottmann; Michaela Scherr; Charu Gupta; Felix F Adams; Adrian Schwarzer; Dirk Heckl; Axel Schambach; Suzan Imren; R Keith Humphries; Arnold Ganser; Felicitas Thol; Michael Heuser
Journal:  Leukemia       Date:  2020-06-24       Impact factor: 11.528

Review 4.  Cytogenetic and Genetic Abnormalities with Diagnostic Value in Myelodysplastic Syndromes (MDS): Focus on the Pre-Messenger RNA Splicing Process.

Authors:  Nathalie Douet-Guilbert; Benoît Soubise; Delphine G Bernard; Marie-Bérengère Troadec
Journal:  Diagnostics (Basel)       Date:  2022-07-07

5.  Prognostic significance of U2AF1 mutations in myelodysplastic syndromes: a meta-analysis.

Authors:  Bixia Li; Duobing Zou; Shujun Yang; Guifang Ouyang; Qitian Mu
Journal:  J Int Med Res       Date:  2019-12-11       Impact factor: 1.671
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.